Further mechanistic studies are needed to understand whether HER2 expression in the lung increases the risk for T-DXd pneumonitis, and whether other ILA or ILD risk markers may be relevant to predict individuals at high risk for T-DXd pneumonitis. Here, ERBB2 is linked to interstitial lung disease.